[Chinese expert consensus on the management of hemorrhagic complications after hematopoietic stem cell transplantation(2021)].
出版信息
Zhonghua Xue Ye Xue Za Zhi. 2021 Apr 14;42(4):276-280. doi: 10.3760/cma.j.issn.0253-2727.2021.04.002.
Abstract
摘要
相似文献
1
[Chinese expert consensus on the management of hemorrhagic complications after hematopoietic stem cell transplantation(2021)].
Zhonghua Xue Ye Xue Za Zhi. 2021 Apr 14;42(4):276-280. doi: 10.3760/cma.j.issn.0253-2727.2021.04.002.
2
[Chinese expert consensus on the diagnosis and management of sinusoidal obstruction syndrome after hematopoietic stem cell transplantation (2022)].
Zhonghua Xue Ye Xue Za Zhi. 2022 Mar 14;43(3):177-183. doi: 10.3760/cma.j.issn.0253-2727.2022.03.001.
3
[Chinese expert consensus on the management of long-term complications after hematopoietic stem cell transplantation (2023)].
Zhonghua Xue Ye Xue Za Zhi. 2023 Sep 14;44(9):717-722. doi: 10.3760/cma.j.issn.0253-2727.2023.09.003.
4
[The Chinese expert consensus on hematopoietic stem cell transplantation for malignant lymphoma(2018)].
Zhonghua Zhong Liu Za Zhi. 2018 Dec 23;40(12):927-934. doi: 10.3760/cma.j.issn.0253-3766.2018.12.011.
5
[Chinese expert consensus on the diagnosis and treatment of venous thromboembolism after hematopoietic stem cell transplantation (2022)].
Zhonghua Xue Ye Xue Za Zhi. 2022 Mar 14;43(3):184-196. doi: 10.3760/cma.j.issn.0253-2727.2022.03.002.
6
The consensus on the monitoring, treatment, and prevention of leukemia relapse after allogeneic hematopoietic stem cell transplantation in China.
Cancer Lett. 2018 Dec 1;438:63-75. doi: 10.1016/j.canlet.2018.08.030. Epub 2018 Sep 11.
7
[Chinese expert consensus on allogeneic hematopoietic stem cell transplantation for cerebral adrenoleukodystrophy (2023)].
Zhonghua Er Ke Za Zhi. 2024 Mar 25;62(4):303-309. doi: 10.3760/cma.j.cn112140-20231019-00302.
8
[Gynecologic care for women undergoing hematopoietic stem cell transplantation: Chinese expert consensus].
Zhonghua Fu Chan Ke Za Zhi. 2022 Jun 25;57(6):401-406. doi: 10.3760/cma.j.cn112141-20211225-00749.
9
[Chinese expert consensus of allogeneic hematopoietic stem cell transplantation for pediatric acute lymphoblastic leukemia (2022)].
Zhonghua Xue Ye Xue Za Zhi. 2022 Oct 14;43(10):793-801. doi: 10.3760/cma.j.issn.0253-2727.2022.10.001.
10
[Chinese expert consensus on the diagnosis and treatment of acute graft-versus-host disease after hematopoietic stem cell transplantation (2024)].
Zhonghua Xue Ye Xue Za Zhi. 2024 Jun 14;45(6):525-533. doi: 10.3760/cma.j.cn121090-20240608-00214.
引用本文的文献
1
Addition of ruxolitinib to standard graft-versus-host disease prophylaxis for allogeneic stem cell transplantation in aplastic anemia patients.
Bone Marrow Transplant. 2024 Jul;59(7):997-1005. doi: 10.1038/s41409-024-02266-7. Epub 2024 Apr 5.
本文引用的文献
1
Avatrombopag for the treatment of immune thrombocytopenia and thrombocytopenia of chronic liver disease.
J Blood Med. 2019 Sep 5;10:313-321. doi: 10.2147/JBM.S191790. eCollection 2019.
2
Eltrombopag for Treating Thrombocytopenia after Allogeneic Stem Cell Transplantation.
Biol Blood Marrow Transplant. 2019 Jul;25(7):1320-1324. doi: 10.1016/j.bbmt.2019.01.027. Epub 2019 Jan 30.
3
Efficacy of recombinant factor VIIa for severe bleeding complicated by platelet transfusion refractoriness in patients with hematologic malignancies.
Thromb Res. 2017 Dec;160:14-18. doi: 10.1016/j.thromres.2017.10.015. Epub 2017 Oct 19.
4
Recombinant Human Thrombopoietin Promotes Platelet Engraftment and Improves Prognosis of Patients with Myelodysplastic Syndromes and Aplastic Anemia after Allogeneic Hematopoietic Stem Cell Transplantation.
Biol Blood Marrow Transplant. 2017 Oct;23(10):1678-1684. doi: 10.1016/j.bbmt.2017.06.010. Epub 2017 Jun 19.
5
Donor-Specific Anti-Human Leukocyte Antigen Antibodies Predict Prolonged Isolated Thrombocytopenia and Inferior Outcomes of Haploidentical Hematopoietic Stem Cell Transplantation.
J Immunol Res. 2017;2017:1043836. doi: 10.1155/2017/1043836. Epub 2017 Apr 16.
6
Clinical characteristics and risk factors of Intracranial hemorrhage in patients following allogeneic hematopoietic stem cell transplantation.
Ann Hematol. 2016 Oct;95(10):1637-43. doi: 10.1007/s00277-016-2767-y. Epub 2016 Aug 3.
7
Use of recombinant factor VIIa in uncontrolled gastrointestinal bleeding after hematopoietic stem cell transplantation among patients with thrombocytopenia.
Pak J Med Sci. 2015 Nov-Dec;31(6):1389-93. doi: 10.12669/pjms.316.8357.
8
Low-Dose Decitabine for Patients With Thrombocytopenia Following Allogeneic Hematopoietic Stem Cell Transplantation: A Pilot Therapeutic Study.
JAMA Oncol. 2015 May;1(2):249-51. doi: 10.1001/jamaoncol.2014.316.
9
Incidence and risk factors for life-threatening bleeding after allogeneic stem cell transplant.
Br J Haematol. 2015 Jun;169(5):719-25. doi: 10.1111/bjh.13344. Epub 2015 Mar 26.
10
Association between an impaired bone marrow vascular microenvironment and prolonged isolated thrombocytopenia after allogeneic hematopoietic stem cell transplantation.
Biol Blood Marrow Transplant. 2014 Aug;20(8):1190-7. doi: 10.1016/j.bbmt.2014.04.015. Epub 2014 May 2.
Zotero 插件